Literature DB >> 33452424

CROP: a CRISPR/Cas9 guide selection program based on mapping guide variants.

Victor Aprilyanto1, Redi Aditama1, Zulfikar Achmad Tanjung1, Condro Utomo2, Tony Liwang1.   

Abstract

The off-target effect, in which DNA cleavage was conducted outside the targeted region, is a major problem which limits the applications of CRISPR/Cas9 genome editing system. CRISPR Off-target Predictor (CROP) is standalone program developed to address this problem by predicting off-target propensity of guide RNAs and thereby allowing the user to select the optimum guides. The approach used by CROP involves generating substitution, deletion and insertion combinations which are then mapped into the reference genome. Based on these mapped variants, scoring and alignment are conducted and then reported as a table comprising the off-target propensity of all guide RNAs from a given gene sequence. The Python script for this program is freely available from: https://github.com/vaprilyanto/crop .

Entities:  

Year:  2021        PMID: 33452424      PMCID: PMC7811000          DOI: 10.1038/s41598-021-81297-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  Applications of CRISPR technologies in research and beyond.

Authors:  Rodolphe Barrangou; Jennifer A Doudna
Journal:  Nat Biotechnol       Date:  2016-09-08       Impact factor: 54.908

2.  Rationally engineered Cas9 nucleases with improved specificity.

Authors:  Ian M Slaymaker; Linyi Gao; Bernd Zetsche; David A Scott; Winston X Yan; Feng Zhang
Journal:  Science       Date:  2015-12-01       Impact factor: 47.728

3.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

4.  CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing.

Authors:  Tessa G Montague; José M Cruz; James A Gagnon; George M Church; Eivind Valen
Journal:  Nucleic Acids Res       Date:  2014-05-26       Impact factor: 16.971

5.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

6.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

Authors:  John G Doench; Nicolo Fusi; Meagan Sullender; Mudra Hegde; Emma W Vaimberg; Jennifer Listgarten; Katherine F Donovan; Ian Smith; Zuzana Tothova; Craig Wilen; Robert Orchard; Herbert W Virgin; David E Root
Journal:  Nat Biotechnol       Date:  2016-01-18       Impact factor: 54.908

7.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets.

Authors:  Shengdar Q Tsai; Nhu T Nguyen; Jose Malagon-Lopez; Ved V Topkar; Martin J Aryee; J Keith Joung
Journal:  Nat Methods       Date:  2017-05-01       Impact factor: 28.547

8.  CRISPR-PLANT v2: an online resource for highly specific guide RNA spacers based on improved off-target analysis.

Authors:  Bastian Minkenberg; Jianwei Zhang; Kabin Xie; Yinong Yang
Journal:  Plant Biotechnol J       Date:  2018-12-13       Impact factor: 9.803

9.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

Authors:  Samuel H Sternberg; Sy Redding; Martin Jinek; Eric C Greene; Jennifer A Doudna
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

10.  A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.

Authors:  Christopher A Vakulskas; Daniel P Dever; Garrett R Rettig; Rolf Turk; Ashley M Jacobi; Michael A Collingwood; Nicole M Bode; Matthew S McNeill; Shuqi Yan; Joab Camarena; Ciaran M Lee; So Hyun Park; Volker Wiebking; Rasmus O Bak; Natalia Gomez-Ospina; Mara Pavel-Dinu; Wenchao Sun; Gang Bao; Matthew H Porteus; Mark A Behlke
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.